Tongjitang Chinese Medicines Co. (ADR) (NYSE:TCM)

CAPS Rating: 3 out of 5

A vertically integrated and profitable specialty pharmaceutical company focusing on the development, manufacturing and marketing of modernized traditional Chinese medicine.

Recs

0
Player Avatar FlyGuy93021 (89.40) Submitted: 9/3/2007 1:05:02 PM : Outperform Start Price: $9.29 TCM Score: -46.52

Regardless what your opinion is of Chinese medicine, it is taken very seriously in China, and among Chinese nationals abroad. They are just beginning to tap a huge market.

Featured Broker Partners


Advertisement